Cell Genesys, Amylin tumble on drug woes
Posted by admin on August 28, 2008 under News | 
Be the First to Comment
Cell Genesys, Amylin tumble on drug woes
BOSTON (MarketWatch) — Drug stocks were mixed in midday action Wednesday as shares of Cell Genesys dived on news that it was discontinuing a key clinical trial for its prostate cancer therapy GVAX du…
Add A Comment